|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 401/14 | (2006.01) |
| A61K 31/4995 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2638033 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11788263.9 |
| Date of filing the European patent application | 2011-11-01 | |
| (97) | Date of publication of the European application | 2013-09-18 |
| (45) | Date of publication and mention of the grant of the patent | 2015-04-08 |
| (46) | Date of publication of the claims translation | 2015-06-25 |
| (86) | Number | PCT/US2011/058692 |
| Date | 2011-11-01 |
| (87) | Number | WO 2012/064548 |
| Date | 2012-05-18 |
| (30) | Number | Date | Country code |
| 411137 P | 2010-11-08 | US |
| (72) |
JOSEPH, Sajan, US
SAMAJDAR, Susanta, US
|
| (73) |
Eli Lilly and Company,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Junginiai, naudingi Chk1 slopinimui |
| COMPOUNDS USEFUL FOR INHIBITING CHK1 |
| Payment date | Validity (years) | Amount | |
| 2024-10-22 | 14 | 289.00 EUR |
| 2025-11-01 |